Consistently, western blot analysis revealed that gemcitabine and MK-8776 treatment for 48 h suppressed the expression of CDK4 and cyclin D1 in bladder cancer cells (Fig. 2b, Fig. S4). The gene discussed is CDK4; the disease is urinary bladder carcinoma.